Defining invasive fungal infections in neutropenic or stem cell transplant patients

Area of Science:

• Medical Mycology
• Infectious Diseases
• Clinical Microbiology

Background:

• Consistent definitions of invasive fungal infections (IFIs) are essential for patient management, clinical trials, and diagnostic test evaluation.
• A systematic review revealed over 25 adverbs used to categorize IFIs, leading to poor agreement when applied to patient data.
• Variability in sensitivity and specificity of clinical features and investigations contributes to inconsistent IFI classification.

Purpose of the Study:

• To review the clinical presentation of IFIs in neutropenic patients and stem cell transplant recipients.
• To evaluate the performance of current diagnostic investigations for IFIs.
• To assess the utility of these factors as criteria for defining IFIs.

Main Methods:

• Systematic literature review of clinical presentations and diagnostic investigations for IFIs.
• Analysis of the performance of diagnostic tools in neutropenic and stem cell transplant patient populations.
• Examination of existing criteria for defining IFIs in clinical research.

Main Results:

• Inconsistent terminology and application of diagnostic criteria hinder reliable IFI classification.
• The European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) definitions offer an international standard for research.
• Ongoing revisions to EORTC/MSG criteria aim to address criticisms and improve standardization.

Conclusions:

• Standardized definitions for invasive fungal infections are critical for research and clinical practice.
• Current diagnostic approaches show variability, necessitating refinement of classification criteria.
• Evolving EORTC/MSG definitions represent a move towards international standardization for IFIs.